May 5, 2026
⚑ Important
Regulation
MHLW Issues Final CBN Enforcement Guidelines Ahead of June 1 Ban
The Ministry of Health, Labour and Welfare published comprehensive enforcement guidelines for the upcoming CBN (cannabinol) prohibition, effective June 1, 2026. The guidelines specify that products containing any detectable amount of CBN will be subject to immediate customs seizure and potential criminal penalties. Importers have been instructed to provide enhanced analytical certificates demonstrating CBN-free status using validated testing methods. The ministry emphasized that transitional periods or exemptions will not be granted for existing inventory.
May 6, 2026
Market
CBG Product Registrations Surge 340% Ahead of CBN Ban
Japan Customs reported a 340% increase in CBG (cannabigerol) product import applications during April, as overseas brands pivot away from CBN-containing formulations. Major North American and European cannabinoid manufacturers are reformulating their Japan-bound product lines to feature CBG as the primary active ingredient. Industry analysts project CBG will capture 60% of the functional cannabinoid market share previously held by CBN products. The shift represents the largest single-month regulatory-driven market reallocation in Japan's cannabinoid sector since CBD legalization.
📰
Japan Customs
·
customs.go.jp
May 7, 2026
⚑ Important
Business
Tokyo Cannabinoid Testing Lab Achieves ISO 17025 Accreditation for Minor Cannabinoids
Nihon Analytical Solutions received ISO 17025 accreditation for minor cannabinoid analysis, becoming Japan's first laboratory certified to test CBG, CBC, and CBGa to pharmaceutical standards. The accreditation enables domestic testing for import compliance, reducing overseas brands' reliance on international laboratories and shortening approval timelines by an estimated 2-3 weeks. The lab's validated methods can detect cannabinoids at 0.01% concentration levels, exceeding regulatory requirements for THC residue monitoring established in December 2024.
📰
Nikkei Shimbun
·
nikkei.com
May 8, 2026
Regulation
National Police Agency Updates Cannabinoid Identification Database
The National Police Agency expanded its controlled substance identification database to include molecular profiles for 47 synthetic cannabinoids and novel derivatives. The update enhances customs screening capabilities for detecting prohibited substances in imported products claiming to contain only legal cannabinoids. Law enforcement officials noted particular focus on identifying designer cannabinoids that may be marketed as CBG or other permitted compounds. The database integration with customs inspection systems becomes operational May 15, 2026.
May 8, 2026
Science
Kyoto University Publishes CBG Bioavailability Study in Japanese Population
Researchers at Kyoto University's Graduate School of Pharmaceutical Sciences published the first comprehensive bioavailability study of CBG in Japanese subjects. The study found significant variations in CBG absorption rates compared to Western populations, with implications for dosing recommendations in Japan-specific formulations. The research identified genetic polymorphisms affecting CBG metabolism that are more prevalent in East Asian populations. These findings are expected to influence regulatory guidance for CBG product labeling and recommended usage protocols for the Japanese market.